Home › Stem Cell Cures

Stem Cell Cures

News Story
6/26/2009
Posted by Consumer Watchdog
The chief scientific officer at California's stem-cell agency has announced that she will step down from her position in a little over a month. Marie Csete, who had been at the San Francisco-based California Institute for Regenerative Medicine (CIRM) for slightly more than a year, has so far offered no specific reasons for leaving the agency,...
News Story
6/25/2009
Posted by Consumer Watchdog
Marie Csete. The resignation of the top science officer at California's stem cell research funding agency, some say, is exposing deeper management problems at the San Francisco-based agency. (Read our Wednesday story here.) It should be noted that at our Bay Area Biotech Forum this morning, panelists didn't mention the departure of Marie Csete...
Blog Post
6/24/2009
Posted by Consumer Watchdog
Dr. Marie Csete has resigned as chief science officer at California's stem cell agency effective Aug. 1 after a little more than a year with the organization. I'd say her departure after such a short tenure -- and with no clear indication of where she is headed next -- speaks volumes about CIRM's management.  Or should I say, mismanagement....
News Story
6/12/2009
Posted by Consumer Watchdog
Bob Klein, the architect of California’s $3 billion stem cell research funding program, will not seek a new term as chairman of the agency. Klein’s six-year term expires at the end of 2010. Klein made the announcement at the California Institute for Regenerative Medicine’s finance subcommittee meeting today, reported the...
Blog Post
6/11/2009
Posted by Consumer Watchdog
Bob Klein, chairman of California's  stem cell agency oversight board, plans to step down at the end of his six-year term in 2010. He made his plans clear during a meeting of the board's Finance Committee Thursday. Klein noted that including his involvement in writing and campaigning for Proposition 71 that created the agency he "will...
Blog Post
5/26/2009
Posted by Consumer Watchdog
Los Angeles Times business columnist Michael Hiltzik has just explored the situation thwarting noncommercial neural stem cell research because of patents controlled by StemCells Inc. of Palto Alto, CA.  Sadly the scientific heavyweights who could resolve the issue with a simple telephone call are remaining mum. I first shed light on the...
News Story
5/25/2009
Posted by Consumer Watchdog
Dr. Philip H. Schwartz spent six years providing university researchers with neural stem cells cultured by a method he had helped invent at the Salk Institute in La Jolla. He figured this was a win-win. His technique provided biomedical scientists with live tissue, an improvement over the dead cells, harvested from the brains of deceased patients...
News Story
5/22/2009
Posted by Consumer Watchdog
Under the Bush Administration, only embryonic stem cell lines derived before 9 pm, Aug. 9, 2001, could receive federal funding. Only two dozen lines qualified. As of result, many scientists conducting stem cell research, wanting federal funding, chose to use the limited pool. These lines continue to be in use today, with many at the heart of...
News Release
5/20/2009
Posted by Consumer Watchdog
NIH Should Fix Standards To Allow Use Of Current Stem Cell Lines Santa Monica, CA -- Regulations governing stem cell research proposed by the Obama Administration -- unless modified before final implementation on July 1 -- prohibit federal funding of important research that had received funding under the Bush Administration, Consumer Watchdog said...
News Story
5/20/2009
Posted by Consumer Watchdog
The president has lifted the Bush restrictions on embryonic stem cell on federal funding for embryonic stem cell research mean for the funding. What does that mean for an oft-criticized state agency with $3 billion in grants to give out? BURLINGAME, CA -- California provides more funding for stem cell research than the other 49 states combined. So...